Mochida reports first-quarter profit growth: what it means for Mochida stock

Published on 10/07/2026 at 03:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mochida revenue reached JPY 31.72 billion in the first quarter, up 7.65 percent. For Mochida stock, net income rose 103.59 percent to JPY 3.18 billion.

Mochida, JP3922800002, Illustration mit AI erstellt.

Mochida (ISIN JP3922800002) reported JPY 3.18 billion in net income for the first quarter ended June 30, 2026, up 103.59 percent from JPY 1.56 billion in the preceding quarter. Investing.com identifies quarterly revenue of JPY 31.72 billion and earnings per share of JPY 89.75 for the period.

Profit growth shapes Mochida stock

The revenue figure increased 7.65 percent from JPY 29.46 billion in the preceding quarter. Net income more than doubled from JPY 1.56 billion, giving the result a sharper earnings improvement than the top-line increase.

The figures cover Mochida Pharmaceutical's pharmaceutical and healthcare-products businesses. MarketWatch describes the company as a Tokyo-based developer, manufacturer and seller of pharmaceuticals, healthcare products and medical equipment.

Tokyo quote stays below yearly high

Mochida was trading at JPY 3,110.00 on the Tokyo Stock Exchange on October 7, 2026 at 10:39 a.m. JST. That level stood JPY 855.00, or 21.56 percent, below the 52-week high of JPY 3,965.00 and JPY 181.00 above the 52-week low of JPY 2,929.00.

TradingView lists October 30, 2026 as Mochida's next earnings date, placing the second-quarter update ahead of the company's fiscal-year end in March 2027.

Next report brings the next test

The Lang & Schwarz prior close was EUR 17.60 on October 5, 2026. Mochida's first-quarter profit comparison therefore gives investors a dated operating benchmark while the Tokyo quotation remains below its yearly peak. The further course of trading is shown by the continuously updated real-time quote of Mochida stock.